CLPP and colorectal carcinoma: Local or systemic administration of CLPP/mIL-15 complex had an obvious inhibitory effect on a variety of C26 CRC mouse models, with inhibition rates of 70%, 55%, and 69% in the CT26 abdominal metastasis model, subcutaneous metastasis model and in the lung metastasis model, respectively.